Cooley, Linklaters Steer Biopharma Genfit's $135M Debut
By Matthew Guarnaccia ( March 27, 2019, 1:21 PM EDT) -- French biopharmaceutical company Genfit SA began trading in the U.S. Wednesday after picking up $135.1 million through an initial public offering and private placement that the Cooley LLP and Linklaters LLP-led firm said it will use to advance treatment for certain liver diseases....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.